Otrivin Nasal Spray

Otrivin is a globally recognized brand specializing in nasal health products, most notably its topical nasal decongestant sprays and drops. Originally developed by the Swiss chemical and pharmaceutical company Ciba (which later merged with Geigy to become Ciba-Geigy, and eventually part of Novartis), the brand has a long history of pharmaceutical excellence rooted in Switzerland.

Today, Otrivin is owned by Haleon plc, a major independent consumer healthcare company that was established as a result of a demerger of GSK's consumer healthcare business in 2022. Haleon is headquartered in the United Kingdom and manages a vast portfolio of leading health brands. Due to its global footprint, Otrivin products are manufactured in various locations worldwide, including major facilities in Switzerland and other regional hubs, to serve markets in Europe, North America, and beyond.